P95, a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases, is

At P95, we believe in the power of movement – not just as a means to personal health, but as

P95 BV, an Ampersand Capital Partners portfolio company, is proud to announce the appointment of Laurence De Moerlooze as Chief

P95 BV, a global leader in clinical and epidemiology research solutions, is excited to announce the strategic acquisition of 4Clinics,

As we approach our 13th anniversary on June 16, we pause to celebrate important milestones and extend our deepest gratitude

P95 has opened its first office in the USA. Based in the Research Triangle Park in North Carolina, the largest